The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset-Reference-Cited by-同舟云学术

The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset

Published:2011-03 Issue:7339 Volume:471 Page:513-517
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Ceol Craig J.,Houvras Yariv,Jane-Valbuena Judit,Bilodeau Steve,Orlando David A.,Battisti Valentine,Fritsch Lauriane,Lin William M.,Hollmann Travis J.,Ferré Fabrizio,Bourque Caitlin,Burke Christopher J.,Turner Laura,Uong Audrey,Johnson Laura A.,Beroukhim Rameen,Mermel Craig H.,Loda Massimo,Ait-Si-Ali Slimane,Garraway Levi A.,Young Richard A.,Zon Leonard I.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09806.pdf

Reference23 articles.

1. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002)

2. Wan, P. T. et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF . Cell 116, 855–867 (2004)

3. Pollock, P. M. et al. High frequency of BRAF mutations in nevi. Nature Genet. 33, 19–20 (2003)

4. Curtin, J. A. et al. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135–2147 (2005)

5. Garraway, L. A. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117–122 (2005)

Cited by 486 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species;Scientific Reports;2024-09-14

2. Setdb1 protects genome integrity in murine muscle stem cells to allow for regenerative myogenesis and inflammation;Developmental Cell;2024-09

3. Epigenetics and ultraviolet radiation: Implications for skin ageing and carcinogenesis;Skin Health and Disease;2024-07-05

4. A chronic signaling TGFb zebrafish reporter identifies immune response in melanoma;eLife;2024-06-14

5. SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer;Drug Discovery Today;2024-05